BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26066800)

  • 1. CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma.
    Martín-Moreno AM; Roncador G; Maestre L; Mata E; Jiménez S; Martínez-Torrecuadrada JL; Reyes-García AI; Rubio C; Tomás JF; Estévez M; Pulford K; Piris MA; García JF
    PLoS One; 2015; 10(6):e0125203. PubMed ID: 26066800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF-1R expression in tumor-associated macrophages is associated with worse prognosis in classical Hodgkin lymphoma.
    Koh YW; Park C; Yoon DH; Suh C; Huh J
    Am J Clin Pathol; 2014 Apr; 141(4):573-83. PubMed ID: 24619759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma.
    Steidl C; Diepstra A; Lee T; Chan FC; Farinha P; Tan K; Telenius A; Barclay L; Shah SP; Connors JM; van den Berg A; Gascoyne RD
    Blood; 2012 Oct; 120(17):3530-40. PubMed ID: 22955918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines.
    Ullrich K; Wurster KD; Lamprecht B; Köchert K; Engert A; Dörken B; Janz M; Mathas S
    Br J Haematol; 2011 Nov; 155(3):398-402. PubMed ID: 21517818
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
    Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
    PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel monocytic phenotype in Classic Hodgkin Lymphoma tumor microenvironment.
    Post GR; Yuan Y; Holthoff ER; Quick CM; Post SR
    PLoS One; 2019; 14(11):e0224621. PubMed ID: 31714922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact.
    Barros MH; Hassan R; Niedobitek G
    Clin Cancer Res; 2012 Jul; 18(14):3762-71. PubMed ID: 22645050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in ATM protein expression during normal lymphoid differentiation and among B-cell-derived neoplasias.
    Starczynski J; Simmons W; Flavell JR; Byrd PJ; Stewart GS; Kullar HS; Groom A; Crocker J; Moss PA; Reynolds GM; Glavina-Durdov M; Taylor AM; Fegan C; Stankovic T; Murray PG
    Am J Pathol; 2003 Aug; 163(2):423-32. PubMed ID: 12875964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfaceome of classical Hodgkin and non-Hodgkin lymphoma.
    Hofmann A; Thiesler T; Gerrits B; Behnke S; Sobotzki N; Omasits U; Bausch-Fluck D; Bock T; Aebersold R; Moch H; Tinguely M; Wollscheid B
    Proteomics Clin Appl; 2015 Aug; 9(7-8):661-70. PubMed ID: 26076441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.
    Guo B; Cen H; Tan X; Ke Q
    BMC Med; 2016 Oct; 14(1):159. PubMed ID: 27745550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line.
    Baus D; Nonnenmacher F; Jankowski S; Döring C; Bräutigam C; Frank M; Hansmann ML; Pfitzner E
    Leukemia; 2009 Oct; 23(10):1885-93. PubMed ID: 19440213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the CD58 gene in classical Hodgkin lymphoma.
    Schneider M; Schneider S; Zühlke-Jenisch R; Klapper W; Sundström C; Hartmann S; Hansmann ML; Siebert R; Küppers R; Giefing M
    Genes Chromosomes Cancer; 2015 Oct; 54(10):638-45. PubMed ID: 26194173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D connectomes of reactive and neoplastic CD30 positive lymphoid cells and surrounding cell types.
    Lumer L; Wurzel P; Scharf S; Schäfer H; Ackermann J; Koch I; Hansmann ML
    Acta Histochem; 2021 Jul; 123(5):151750. PubMed ID: 34233254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells.
    Eppler E; Janas E; Link K; Weidmann L; Bischofberger H; Wenger M; Tinguely M; Schraml P; Moch H; Fellbaum C
    Cell Tissue Res; 2015 Mar; 359(3):841-51. PubMed ID: 25487403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody.
    Agostinelli C; Paterson JC; Gupta R; Righi S; Sandri F; Piccaluga PP; Bacci F; Sabattini E; Pileri SA; Marafioti T
    Histopathology; 2012 Jul; 61(1):33-46. PubMed ID: 22394247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.
    Klein JL; Nguyen TT; Bien-Willner GA; Chen L; Foyil KV; Bartlett NL; Duncavage EJ; Hassan A; Frater JL; Kreisel F
    Am J Clin Pathol; 2014 Mar; 141(3):381-7. PubMed ID: 24515766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.